ENTA Stock Analysis: Buy, Sell, or Hold?
ENTA - Enanta Pharmaceuticals, Inc
$13.67
-0.04 (-0.29%)
▼
5d:
-0.87%
30d:
+12.23%
90d:
+8.06%
BUY
HIGH Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 11, 2026
11d
Smart Money Distribution
ENTA is up 6.3% this week, but smart money is buying puts. Top strike: $17.5 2026-05-15 with 1 OI. Put ratio: 100% View Scanner →
Strength: 8.2/10
Get Alerted When ENTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ENTA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ENTA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ENTA is currently trading at $13.67, which is considered fair relative to its 30-day fair value range of $12.63 to $14.09.
Technical Outlook: Technically, ENTA is in a downtrend. Immediate support is located at $12.80, while resistance sits at $14.89.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.86 (+44.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ENTA is in a downtrend. Immediate support is located at $12.80, while resistance sits at $14.89.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (2th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.86 (+44.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$12.63 -
$14.09
Company Quality Score
52/100
(HOLD)
Options IV Signal
2th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 2th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.8% below Wall St target ($19.86)
Trading Range Analysis
30-Day Trading Range
$12.63 -
$14.09
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.92
(14.0%)
Support & Resistance Levels
Support Level
$12.80
Resistance Level
$14.89
Current Trend
Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.55
Wall Street Target
$19.86
(+44.8%)
Revenue Growth (YoY)
9.8%
Earnings Growth (YoY)
-66.2%
Profit Margin
-106.8%
Share & Embed Analysis
Last updated: April 29, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Brendan Luu
SELL
1394 shares
2025-12-05
Jay R Luly
SELL
4743 shares
2025-12-05
Kathleen S Capps
SELL
323 shares
2025-12-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 52 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 57 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$298 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 57 HOLD |
Advanced ENTA Option Strategies
Professional options setups generated by AI based on today's ENTA price and gamma walls.
